Comparative Genomic and Genetic Analysis of Paired Primary Breast - Metastatic Tumor Specimens Using High-throughput Platforms
NCT01227733 · Status: UNKNOWN · Type: OBSERVATIONAL
Last updated 2014-01-22
Summary
Adequate quality and quantity of RNA may be extracted from paraffin-embedded tumor blocks for gene expression analysis. This has clinical relevance as gene expression signatures may then be profiled using archival tumor blocks, which are more readily available than frozen tissues.
Conditions
Interventions
- OTHER
-
Breast Tumor Blocks
Sponsors & Collaborators
-
National University Hospital, Singapore
lead OTHER
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-08-31
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- Singapore
Study Locations
More Related Trials
-
Study of Circulating and Tumor Biomarkers in Breast Cancer Patients
NCT01866202 ·Status: UNKNOWN
-
Cohort Study of Patients With HER2-negative MBC and BRCA 1/2 Pathogenic Mutation
NCT04368442 ·Status: UNKNOWN
-
Breast Cancer Molecular Analysis Protocol
NCT01855503 ·Status: COMPLETED
-
Prophylactic Mastectomy: Prospective Evaluation of the Correlation Between Skin Flap Thickness, Residual Glandular Tissue and Skin Necrosis by Imaging and Clinical Examination
NCT05162677 ·Status: RECRUITING
-
Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy
NCT01198301 ·Status: COMPLETED
-
Genetic and Protein Profiling in Normal and Cancerous Breast Tissue
NCT00083733 ·Status: COMPLETED
-
Molecular Signature for Breast Cancer
NCT05724407 ·Status: UNKNOWN
-
Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer
NCT00001496 ·Status: COMPLETED
-
Mutation of BRCA1/2 and Other Potential Genes in Triple-negative Breast Cancer
NCT02670668 ·Status: UNKNOWN ·Phase: NA
-
Comparison of CNB and Surgical Specimens for ER, PgR, HER2 Status and Ki67 Index in Invasive Breast Cancer.
NCT02773784 ·Status: COMPLETED
-
Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28
NCT01420185 ·Status: UNKNOWN
-
MRD in High-risk EBC
NCT06566729 ·Status: ACTIVE_NOT_RECRUITING
-
Using a Blood Test to Monitor Metastatic Breast Cancer Treatment
NCT05804578 ·Status: RECRUITING
-
Study of Tumor and Blood Samples From Women With Breast Cancer
NCT00897728 ·Status: UNKNOWN
-
Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery
NCT00233974 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular Analysis of Breast Cancer
NCT00569049 ·Status: COMPLETED
-
Whole Genome Sequencing in Breast Cancer
NCT06334471 ·Status: RECRUITING
-
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
NCT00463034 ·Status: UNKNOWN
-
Korean Hereditary Breast Cancer Study
NCT00595348 ·Status: UNKNOWN
-
Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer
NCT05079074 ·Status: COMPLETED
-
Patient-reported Outcome Questionnaire for Women With Metastatic Breast Cancer
NCT01282931 ·Status: COMPLETED
-
Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer
NCT01460186 ·Status: COMPLETED ·Phase: NA
-
Lymph Fluid and Blood Collection for Identification of Novel Biomarkers
NCT01075607 ·Status: TERMINATED
-
Characterizing Breast Cancer With 68Ga-FAPI PET/CT (PFB-01)
NCT05574907 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Sentinel Lymph Node Biopsy With or Without Para-Sentinel Lymph Node Dissection in Breast Cancer
NCT02651142 ·Status: UNKNOWN ·Phase: NA